antibodies
-
Danaher Continues M&A Streak, Buying Life Sciences Firm Abcam for $5.7B
Abcam’s acquisition comes two months after its board announced the exploration of strategic alternatives that could include the sale of the company. Danaher beat out at least 20 companies that were potential buyers of the life sciences tools and antibody development firm.
-
MIT Clears Bioengineering Professor of Research Misconduct Allegations
Massachusetts Institute of Technology Bioengineering Professor Ram Sasisekharan and his lab have been cleared of research misconduct allegations following a lengthy university investigation.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
StartUPDATES: New developments from healthcare startups
News from innovative healthcare startups from Specifica, Aerovate Therapeutics and more.
-
Cambridge-based Compass Therapeutics raising $120M for antibody discovery work
Compass Therapeutics, formed by leadership at fellow antibody discovery company Adimab, is raising $120 million.